BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19212702)

  • 1. Adrenomedullin and endothelin-1 are related to inflammation in chronic heart failure.
    Gombos T; Förhécz Z; Pozsonyi Z; Wallentin S; Papassotiriou J; Kunde J; Morgenthaler NG; Jánoskuti L; Prohászka Z
    Inflamm Res; 2009 Jun; 58(6):298-305. PubMed ID: 19212702
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating tumor necrosis factor-alpha levels in chronic heart failure: relation to its soluble receptor II, interleukin-6, and neurohumoral variables.
    Koller-Strametz J; Pacher R; Frey B; Kos T; Woloszczuk W; Stanek B
    J Heart Lung Transplant; 1998 Apr; 17(4):356-62. PubMed ID: 9588580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-based microcirculation markers in Alzheimer's disease-diagnostic value of midregional pro-atrial natriuretic peptide/C-terminal endothelin-1 precursor fragment ratio.
    Buerger K; Ernst A; Ewers M; Uspenskaya O; Omerovic M; Morgenthaler NG; Knauer K; Bergmann A; Hampel H
    Biol Psychiatry; 2009 Jun; 65(11):979-84. PubMed ID: 19344890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of plasma midregional pro-adrenomedullin and C-terminal-pro-endothelin-1 in chronic heart failure outpatients.
    Adlbrecht C; Hülsmann M; Strunk G; Berger R; Mörtl D; Struck J; Morgenthaler NG; Bergmann A; Jakowitsch J; Maurer G; Lang IM; Pacher R
    Eur J Heart Fail; 2009 Apr; 11(4):361-6. PubMed ID: 19190023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromogranin A and C-terminal endothelin-1 precursor fragment add independent prognostic information to amino-terminal proBNP in patients with acute destabilized heart failure.
    Dieplinger B; Gegenhuber A; Struck J; Poelz W; Langsteger W; Haltmayer M; Mueller T
    Clin Chim Acta; 2009 Feb; 400(1-2):91-6. PubMed ID: 19000665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma levels of adrenomedullin and atrial natriuretic peptide in patients with congestive heart failure of various etiologies.
    Randa Abdel Kader M; Grace BD; Badawi NE
    Ital J Biochem; 2007 Mar; 56(1):18-27. PubMed ID: 17511350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma MR-proADM correlates to BMI and decreases in relation to leptin after gastric bypass surgery.
    Vila G; Riedl M; Maier C; Struck J; Morgenthaler NG; Handisurya A; Prager G; Ludvik B; Clodi M; Luger A
    Obesity (Silver Spring); 2009 Jun; 17(6):1184-8. PubMed ID: 19247278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetics of humoral and cytokine activation in heart failure and its importance for risk stratification of patients.
    Spinarová L; Spinar J; Vasků A; Pávková-Goldbergová M; Ludka O; Tomandl J; Vítovec J
    Exp Mol Pathol; 2008 Jun; 84(3):251-5. PubMed ID: 18442814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic performance of mid-regional pro-adrenomedullin as an analyte for the exclusion of left ventricular dysfunction.
    Elmas E; Lang S; Dempfle CE; Kälsch T; Papassotiriou J; Morgenthaler NG; Borggrefe M; Brueckmann M
    Int J Cardiol; 2008 Aug; 128(1):107-11. PubMed ID: 17698224
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure.
    Windram JD; Loh PH; Rigby AS; Hanning I; Clark AL; Cleland JG
    Am Heart J; 2007 Jun; 153(6):1048-55. PubMed ID: 17540208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in plasma levels of adrenomedullin and cyclic adenosine monophosphate and their interrelation in patients with chronic heart failure].
    Yan QN; Li ZL; Wu HC; Chen YQ; Chen Q; Lu Q
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Sep; 22(9):803-5. PubMed ID: 12297436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adrenomedullin on the production of endothelin-1 and on its vasoconstrictor action in resistance arteries: evidence for a receptor-specific functional interaction in patients with heart failure.
    Hillier C; Petrie MC; Love MP; Johnston F; MacLean MR; McMurray JJ
    Clin Sci (Lond); 2001 Jul; 101(1):45-51. PubMed ID: 11410113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The acute effect of Metoprolol upon NT-proBNP level in patients with congestive heart failure.
    Zdrenghea D; Pop D; Ilea M; Bodisz G; Mălai A; Zdrenghea M
    Rom J Intern Med; 2009; 47(1):35-40. PubMed ID: 19886067
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenomedullin and endothelin-1 are associated with myocardial injury and death in septic shock patients.
    Lundberg OH; Bergenzaun L; Rydén J; Rosenqvist M; Melander O; Chew MS
    Crit Care; 2016 Jun; 20(1):178. PubMed ID: 27282767
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of plasma adrenomedullin and proadrenomedullin N-terminal 20 peptide concentrations in patients with heart failure.
    Gao YQ; Li ZL; Wu HC; Tang CS; Zhong P; Lu Q; Yan QN
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):632-4. PubMed ID: 12376296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasoregulatory peptides pro-endothelin-1 and pro-adrenomedullin are associated with metabolic syndrome in the population-based KORA F4 study.
    Seissler J; Feghelm N; Then C; Meisinger C; Herder C; Koenig W; Peters A; Roden M; Lechner A; Kowall B; Rathmann W
    Eur J Endocrinol; 2012 Dec; 167(6):847-53. PubMed ID: 23002189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of midregional pro-atrial and B-type natriuretic peptides in chronic heart failure: influencing factors, detection of left ventricular systolic dysfunction, and prediction of death.
    Moertl D; Berger R; Struck J; Gleiss A; Hammer A; Morgenthaler NG; Bergmann A; Huelsmann M; Pacher R
    J Am Coll Cardiol; 2009 May; 53(19):1783-90. PubMed ID: 19422985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction in circulating testosterone relates to exercise capacity in men with chronic heart failure.
    Jankowska EA; Filippatos G; Ponikowska B; Borodulin-Nadzieja L; Anker SD; Banasiak W; Poole-Wilson PA; Ponikowski P
    J Card Fail; 2009 Jun; 15(5):442-50. PubMed ID: 19477405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red cell distribution width in heart failure: prediction of clinical events and relationship with markers of ineffective erythropoiesis, inflammation, renal function, and nutritional state.
    Förhécz Z; Gombos T; Borgulya G; Pozsonyi Z; Prohászka Z; Jánoskuti L
    Am Heart J; 2009 Oct; 158(4):659-66. PubMed ID: 19781428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.